Secretory Kin17 is correlated with chemoresistance in oral squamous cell carcinoma

Journal of Analytical Oncology

Volumn 3, Issue 1, 2014, Pages 18-25

  Liu, Xiaoyi ^a,b   Deng, Lijuan ^a   Zhang, Haixia ^a   Zeng, Tao ^a   Wang, Hua ^a   Zhang, Yan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Chemoresistance; DNA damage; Kin17; Oral cancer; Secretory protein

Indexed keywords

EID: 84904869185     PISSN: 19277210     EISSN: 19277229     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Angulo JF, Moreau PL, Maunoury R, Laporte J, Hill AM, Bertolotti R, Devoret R. KIN, a mammalian nuclear protein immunologically related to E. coli RecA protein. Mutat Res JT -Mutation Research 1989; 217: 123-34. http://dx.doi.org/10.1016/0921-8777(89)90064-5
2. Kannouche PP, Mauffrey G, Pinon-Lataillade MG, Mattei A, Sarasin L. Molecular cloning and characterisation of the human Kin17 cDNA encoding a component of the UVC response that is conserved among metazoans. Carcinogenesis 2000; 21: 1701-10. http://dx.doi.org/10.1093/carcin/21.9.1701
3. Carlier L, Couprie J, le Maire A, Guilhaudis L, Milazzo-Segalas I, Courçon M, et al. Solution structure of the region 51-160 of human KIN17 reveals an atypical winged helix domain. Protein Sci 2007; 16: 2750-5. http://dx.doi.org/10.1110/ps.073079107
4. Mazin A, Milot E, Devoret R, Chartrand P. KIN17, a mouse nuclear protein, binds to bent DNA fragments that are found at illegitimate recombination junctions in mammalian cells. Mol Gen Genet 1994; 244: 435-8. http://dx.doi.org/10.1007/BF00286696
5. Mazin A, Timchenko T, Menissier-de Murcia J, Schreiber V, Angulo JF, de Murcia G, Devoret R. Kin17, a mouse nuclear zinc finger protein that binds preferentially to curved DNA. Nucl Acids Res 1994; 22: 4335-41. http://dx.doi.org/10.1093/nar/22.20.4335
6. Tissier A, Kannouche P, Mauffrey P, Allemand I, Frelat G, Devoret R, Angulo JF. Molecular cloning and characterization of the mouse Kin-17 gene coding for a Zn-finger protein that preferentially recognizes bent DNA. Genomics 1996; 38: 238-42. http://dx.doi.org/10.1006/geno.1996.0623
7. Biard DS, Saintigny Y, Maratrat M, Paris F, Martin M, Angulo JF. Enhanced expression of the kin17 protein immediately after low doses of ionizing radiation. Radiat Res 1997; 147: 442-50. http://dx.doi.org/10.2307/3579501
8. Masson C, Menaa F, Pinon-Lataillade G, Frobert Y, Chevillard S, Radicella JP, et al. Global genome repair is required to activate KIN17, a UVC responsive gene involved in DNA replication. Proc Natl Acad Sci USA 2003; 100: 616-21. http://dx.doi.org/10.1073/pnas.0236176100
9. Biard DS, Miccoli L, Despras E, Frobert Y, Creminon C, Angulo JF. Ionizing radiation triggers chromatin-bound kin17 complex formation in human cells. J Biol Chem 2002; 277: 19156-65. http://dx.doi.org/10.1074/jbc.M200321200
10. Miccoli L, Frouin I, Novac O, Di Paola D, Harper F, Zannis-Hadjopoulos M, et al. The human stress-activated protein kin17 belongs to the multiprotein DNA replication complex and associates in vivo with mammalian replication origins. Mol Cell Biol 2005; 25: 3814-30. http://dx.doi.org/10.1128/MCB.25.9.3814-3830.2005
11. Miccoli L, Biard DS, Frouin I, Harper F, Maga G, Angulo JF. Selective interactions of human kin17 and RPA proteins with chromatin and the nuclear matrix in a DNA damage and cell cycle-regulated manner. Nucleic Acids Res 2003; 31: 4162-75. http://dx.doi.org/10.1093/nar/gkg459
12. Pinon-Lataillade G, Masson C, Bernardino-Sgherri J, Henriot V, Mauffrey P, Frobert Y, et al. KIN17 encodes an RNAbinding protein and is expressed during mouse spermatogenesis. J Cell Sci 2004; 117: 3691-702. http://dx.doi.org/10.1242/jcs.01226
13. Cloutier P, Lavallée-Adam M, Faubert D, Blanchette M, Coulombe B. Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. J Proteomics 2013. http://dx.doi.org/10.1016/j.jprot.2013.10.008
14. Zeng T, Gao H, Yu P, He H, Ouyang X, Deng L, Zhang Y. Up-regulation of kin17 is essential for proliferation of breast cancer. PLoS One 2011; 6(9): e25343. http://dx.doi.org/10.1371/journal.pone.0025343
15. Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 2003; 21: 327-33. http://dx.doi.org/10.1200/JCO.2003.06.146
16. Ma J, Liu Y, Yang X, Zhang CP, Zhang ZY, Zhong LP. Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis. World J Surg Oncol 2013; 11: 67. doi: 10.1186/1477-7819-11-67. http://dx.doi.org/10.1186/1477-7819-11-67
17. Zhang Y, Wang H, Toratani S, Sato JD, Kan M, McKeehan WL, Okamoto T. Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci USA 2001; 98: 11336-40. http://dx.doi.org/10.1073/pnas.191377098
18. Wang L, Mosel AJ, Oakley GG. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer. Mol Cancer Ther 2012; 11: 2401-9. http://dx.doi.org/10.1158/1535-7163.MCT-12-0448
19. Colevas AD. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2006; 24: 2644-52. http://dx.doi.org/10.1200/JCO.2005.05.3348
20. Gu Y, Fan S, Xiong Y, Peng B, Zheng G, Yu Y, et al. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line. FEBS Lett 2011; 585: 881-7. http://dx.doi.org/10.1016/j.febslet.2010.12.045
21. Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelialmesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012; 31: 432-45. http://dx.doi.org/10.1038/onc.2011.263
22. Angulo JF, Rouer E, Mazin A, Mattei MG, Tissier A, Horellou P, et al. Identification and expression of the cDNA of KIN17, a zinc-finger gene located on mouse chromosome 2, encoding a new DNA-binding protein. Nucleic Acids Res 1991; 19: 5117-23. http://dx.doi.org/10.1093/nar/19.19.5117
23. Robbins J, Dilworth SM, Laskey RA, Dingwall C. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 1991; 64: 615-23. http://dx.doi.org/10.1016/0092-8674(91)90245-T
24. Cleves AE. Protein transports: the nonclassical ins and outs. Curr Biol 1997; 7: 318-20. http://dx.doi.org/10.1016/S0960-9822(06)00148-5
25. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999; 1473: 172-85. http://dx.doi.org/10.1016/S0304-4165(99)00177-4
26. Wakisaka N, Murono S, Yoshizaki T, Furukawa M, Pagano JS. Epstein-barr virus latent membrane protein l induces and causes release of fibroblast growth factor-2. Cancer Res 2002; 62: 6337-44. http://cancerres.aacrjournals.org/content/62/21/6337.long
27. Maizel A, Tassetto M, Filhol O, Cochet C, Prochiantz A, Joliot A. Engrailed homeoprotein secretion is a regulated process. Development 2002; 129: 3545-53. http://dev.biologists.org/content/129/15/3545.long
28. Stoorvogel W, Kieijmeer MJ, Geuze Ill, Raposo G. The biogenesis and functions of exosomes. Traffic 2002; 3: 321-30. http://dx.doi.org/10.1034/j.1600-0854.2002.30502.x
29. Lancaster GI, Febbraio MA. Exosome-dependent trafficking of HSP70: A novel secretory pathway for cellular stress proteins. J Bio Chem 2005; 280: 23349-55. http://dx.doi.org/10.1074/jbc.M502017200
30. Yu M, Ocana A, Tannock IF. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit? Cancer Metastasis Rev 2013; 32: 211-27. http://dx.doi.org/10.1007/s10555-012-9402-8
31. Cai BL, Xu XF, Fu SM, Shen LL, Zhang J, Guan SM, Wu JZ. Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma. Oral Oncol 2011; 47: 1134-40. http://dx.doi.org/10.1016/j.oraloncology.2011.08.005
32. Lecerf-Schmidt F, Peres B, Valdameri G, Gauthier C, Winter E, Payen L, et al. ABCG2: recent discovery of potent and highly selective inhibitors. Future Med Chem 2013; 5: 1037-45. http://dx.doi.org/10.4155/fmc.13.71
33. Stacy AE, Jansson PJ, Richardson DR. Molecular pharmacology of ABCG2 and its role in chemoresistance. Mol Pharmacol 2013; 84: 655-69. http://dx.doi.org/10.1124/mol.113.088609